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The applicability agenda of modern Biotechnology needs
no explanation or justiﬁcation. As any technology, the
ultimate value of Biotech is to deliver materials, mole-
cules or processes of interest for the medical, agricul-
tural and environmental market. However, if one takes a
look at high-impact journals or reads grant proposals on
topics presented as Biotechnological research, one legiti-
mately wonders when and how the many exciting results
and concepts that often make headlines will get close to
actual, beneﬁcial uses to society and economy. There is
indeed a Valley of Death in terms of funding between
original scientiﬁc discoveries and applications that is typi-
cally punctuated by the scores (1–9) of the so-called
Technical Readiness Level (TLR). But – important as it
is – in our opinion, the issue is not just about funding but
also about overcoming the conundrum exciting vs.
important. The ﬁrst gets all the attention, receives all
funding and it is frequently published in prestigious jour-
nals. No surprise that the most creative minds ﬂock to
identify and get engaged in exciting endeavours, not the
least because of the career beneﬁts involved. However,
exciting seminal discoveries in Biotechnology are worth
nothing if they are not followed up all the way to techno-
logical readiness. Fleming’s observations on penicillin
had to wait two decades until Florey and Chain ﬁgured
out ways to scale-up the production process. But who
remembers the last two? In sum, it seems that ﬁnding or
developing properties with a biotechnological potential is
exciting. But scaling up and designing processes is per-
ceived as boring, a sort of second-level endeavour to be
addressed also by second-level professionals. In this
Crystal Ball, we would like to take the opportunity to
argue how wrong this is.
Scale-up is in fact the most important bottleneck that
contemporary Biotech has to address if it is to ﬁnd its
niche in a large-scale industrial landscape. This is differ-
ent from the small-scale production of very high added
value biomolecules, such as pharmaceuticals, and the
GMO-based agriculture. Let us take an example close to
the core Microbial Biotech agenda: whole-cell catalysis
and biotransformations. The literature has plenty of
metabolic engineering cases where microbial strain A (or
even an artiﬁcial consortium) is heavily refactored geneti-
cally by scientist B to produce compound C (biopoly-
mers, biofuels, fragrances, food additives, speciality
chemicals etc.). Although the yields are typically not
great, the high-prominence work on this project done by
researcher B often stops there (the generation of a new
property). What happens next (if it does) generally disap-
pears from the high-visibility radar and B moves on to
engineer another strain A that produces another interest-
ing molecule C and so on. The scale-up and the down-
stream processing (the most limiting factors for raising
industrial interest) are taken for granted, handed over to
engineers and generally considered devoid of much
interest. This state of affairs creates a scenario in which
genetic and metabolic engineering of biological systems
advance at the speed of light. But process engineering
seems to be stuck in century-old principles.
The iconic and still prevailing production setup for bio-
molecules synthesized by microorganisms is that of a
fed-batch fermentor with sizes anywhere between milli-
litres to cubic metres, inoculated with a single strain and
grown in a sterile culture medium. After fermentation, the
biomass has to be separated, the product of interest
extracted and the liquid medium disposed of as waste.
While much of the progress in reactor design has
focused on automation and control, in reality the princi-
ples behind such fed-batch fermentations are not that
different from ancient Egyptians producing beer thou-
sands of year ago! Can we do better? The answer is
yes, provided that we reformulate what appears to some
like mere technicalities into exciting research issues. Let
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us just comment on a few of these questions, the ﬁrst of
which is the genetic design of whole-cell catalysts.
For example, we still know very little on how microor-
ganisms adapt to living in a bioreactor. It is important to
note that this is an artiﬁcial niche and the biological
agenda of the catalyst (as in any other place) is about
surviving and thriving in such an unusual scenario. Thus,
in addressing this relationship, the interplay between the
fundamentals of ecology (the niche) and evolution (how
the catalyst adapts), becomes highly relevant to this pro-
saic industrial process. One conveniently ignored issue
is that the fermentor niche is known to be ﬂuctuating as
it is impossible to fully mix large-scale industrial reactors
to virtual homogeneity. This creates zones where glu-
cose limitation, pH ﬂuctuations and oxygen restriction
are a common occurrence and can lead to physiological
stress placed on the production organism (Glazyrina
et al., 2010; Neubauer and Junne, 2010). Recent studies
on long-term residence of E. coli in a continuous reactor
have revealed a suite of genes of unknown function that
get turned on and off (and even deleted) under such
conditions (Lofﬂer et al., 2016) demonstrating the impact
of fermentor ecology on evolution. Therefore, this
change of biological agenda in response to localized
changes in the environments that the whole catalysts go
through points to the importance of gene–environment
interactions and is something that should be considered
during genome design. Up until now, design strategies
are heavily directed to reducing metabolic burden, which
is an important consideration (Borkowski et al., 2016;
Ceroni et al., 2016). Also, the genomes of industrial
strains have been edited to reinforce stress resistance
and strengthen metabolic capacity by, for example
removing ATP and NADH-consuming functions (Lieder
et al., 2015). However, genome-reduced strains origi-
nally created for increasing predictability of biotechnolo-
gical processes turned out to fare worse than non-
reduced counterparts in environments that recreate
stresses typical of these industrial transformations
(Couto et al., 2018). Thus, genome reduction strategies
that exclusively focus on metabolic burden might have
unexpectedly led to the removal of genes that enable
the organism to respond to its changing environment. To
remedy this, the genome designer needs to strike a ba-
lance between reducing metabolic burden and enabling
the organism to persist in the process environment. It is
possible that to enable this one must consider the mini-
mal gene network required for robust growth instead of
the minimal number of genes for robust growth. Criti-
cally, this gene network might only become obvious in
growth conditions the catalyst will face during the pro-
cess, as opposed to in ideal Laboratory conditions, and
we must incorporate this into our routine experimental
procedures.
A second issue is that of large volumes of liquid
needed for the culture medium in fermentations. With the
exception of marine and freshwater microorganisms,
most bacteria habitually live and thrive under sub-satu-
rating humidity conditions. Why do we need to use so
much water in our fermentations, which complicates
downstream processing and generates much waste?
One way to go is developing high-density processes or
even slurry-based processes. But the real breakthrough
would be having transformations occurring with no or
very little added water, that is a sort of composting or
solid-phase fermentations (Arora et al., 2018). We have
precedent here as anaerobic digestion (AD), a biological
process that is now a ﬁrmly established energy-from-
waste biotechnology is known to be most efﬁcient with
high-solid/low water-containing waste streams. Impor-
tantly, although this process has been in use since the
16th century, the reactor has gone through various
design iterations on its journey from early small-scale
operations to biogas reﬁnery. Unlike fermentations, AD
retains the biomass as granular bioﬁlms that mix with
feedstock for a set hydraulic retention time, during which
organic materials are metabolized, leaving less harmful
products. The chemicals of interest could then be engi-
neered for being secreted – thereby negating the need
for breaking up the biomass for extractions. Simultane-
ously, reactors could be redesigned to contain a series
of membrane structures or scaffolds that house or retain
this biomass within the reactor. In this case, there is
much inspiration to get – once again – from naturally
occurring systems. Instead of one-pot reactors, new set-
tings could be entertained mimicking a large-scale,
metabolically super-active multicellular organism such as
a rubber tree or an organ such as an udder where sim-
ple feedstocks diffuse through the system for a set
hydraulic retention time during which the bioconversion
to valuable chemicals takes place. Note also that such
natural reactors operate without sterilization and deliver
products nearly ready to use. There is much room for
improving this feature as well. As proposed recently one
can design large-scale production of bioplastics in non-
sterile conditions by growing engineered Halomonas sp.
in seawater, a niche that can hardly be contaminated by
non-marine bacteria (Chen et al., 2018). We do not wish
to annoy our dear bioprocess engineering colleagues,
but we cannot avoid the feeling that the ﬁeld has been
far more conservative and less creative than the coeta-
neous advances in the genetic design of biological cata-
lysts brought about by contemporary Systems and
Synthetic Biology!
In sum, in this CB we envision that for the so-called
4th Industrial Revolution (Schwab, 2017) to equal the
impact of its predecessors in the Biotechnological realm,
a radical redesign of the bioprocess requires us to go
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back to the fundamentals of ecology and evolution as
well as creatively rethinking both the organism and its
environment. And in asking these fundamental questions
we place ourselves in the position of doing exciting
research while at the same addressing important prob-
lems.
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